Biora Therapeutics announced the appointment of Ariella Kelman, MD, as Chief Medical Officer. Dr. Kelman has a proven track record of leading global biopharmaceutical development, clinical trials, and regulatory strategies. Before joining Biora Therapeutics, Dr. Kelman led clinical development at Human Immunology Biosciences, a clinical-stage company focused on drug discovery and development for immune-mediated conditions.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BIOR:
- Biora Therapeutics Appoints Dr. Ariella Kelman as Chief Medical Officer
- Biora Therapeutics to Participate in Crohn’s & Colitis Foundation’s IBD Innovate Conference
- Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
- Biora Therapeutics Inc. (BIOR) Q4 Earnings Cheat Sheet
- Biora Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update